arrow
W

William Senapedis

karyopharm therapeutics
H指数:34
被引数:3,701

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: PAK4 inhibition improves PD-1 blockade immunotherapy

作者更正:PAK4 抑制可增强 PD-1 阻断免疫疗法

2026-10-090
PRE
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers
2023-09-134
OAAI
A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma
2021-11-3012
OA
PAK4 inhibition improves PD-1 blockade immunotherapy (vol 1, pg 46, 2020)
2020-01-221
OAAI
PAK4 inhibition improves PD-1 blockade immunotherapy
2019-12-09108
OAAI
Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia
2019-01-2846
OA